← Older revision

Revision as of 06:44, 27 October 2026

(One intermediate revision by the same user not shown)

Line 3:

<table><tr><td>

<table><tr><td>

−

Marcel Dinger is Professor of Genome Biology and [https://www.sydney.edu.au/science/about/our-people.html Dean of Science] at the [https://www.sydney.edu.au University of Sydney]. He has 23 years' experience in genomics as both an academic and entrepreneur. He has published [https://www.webofscience.com/wos/author/record/2152005 173 papers] that have collectively been cited [https://scholar.google.com.au/citations?user=UFNwjvsAAAAJ&hl=en>38,000 times] ([https://scholar.google.com.au/citations?user=UFNwjvsAAAAJ&hl=en Google Scholar h-index 76]) and is (co)-founder of four startups in biotechnology and IT. He is a board director of [https://pryzm.health/ Pryzm Health], a digital health enterprise focused on optimising patient care by empowering physicians with AI-based clinical decision support technology.

+

Marcel Dinger is Professor of Genome Biology and [https://www.sydney.edu.au/science/about/our-people.html Dean of Science] at the [https://www.sydney.edu.au University of Sydney]. He has 23 years' experience in genomics as both an academic and entrepreneur. He has published [https://www.webofscience.com/wos/author/record/2152005 173 papers] that have collectively been cited [https://scholar.google.com.au/citations?user=UFNwjvsAAAAJ&hl=en>39,000 times] ([https://scholar.google.com.au/citations?user=UFNwjvsAAAAJ&hl=en Google Scholar h-index 78]) and is (co)-founder of four startups in biotechnology and IT. He is a board director of [https://pryzm.health/ Pryzm Health], a digital health enterprise focused on optimising patient care by empowering physicians with AI-based clinical decision support technology.

Marcel served as Head of [https://www.unsw.edu.au/science/our-schools/babs School of Biotechnology and Biomolecular Sciences] at [https://www.unsw.edu.au UNSW Sydney] from 2019 to 2022. Prior to his role at UNSW, Marcel was the Founding Chief Executive Officer of Genome.One, one of the first companies in the world to provide clinical whole genome sequencing services, and inaugural Head of the [http://www.garvan.org.au/research/kinghorn-centre-for-clinical-genomics/clinical-genomics Kinghorn Centre for Clinical Genomics] (KCCG) at the [https://garvan.org.au/ Garvan Institute of Medical Research]. As CEO of Genome.One, he brought together his expertise in informatics, biology and business to manage and direct a world-class clinical genomics service. As Head of KCCG, Marcel led a translational research laboratory that aimed to realise the utility of genomic medicine in routine clinical practice and explore the clinical value of non-protein-coding regions of the genome. Prior to moving to Sydney, Marcel headed the Cancer Transcriptomics laboratory at the [http://www.di.uq.edu.au/ Diamantina Institute] at the [http://www.uq.edu.au/ University of Queensland]. Marcel undertook his postdoctoral studies at the [http://imb.uq.edu.au/ Institute for Molecular Bioscience] where he studied the role of long noncoding RNAs in mammalian development and disease. During his postdoc, Marcel led a number of key studies demonstrating the dynamic and specific expression of long noncoding RNAs that prompted extensive functional studies of these transcripts that were commonly assumed to be “junk”.

Marcel served as Head of [https://www.unsw.edu.au/science/our-schools/babs School of Biotechnology and Biomolecular Sciences] at [https://www.unsw.edu.au UNSW Sydney] from 2019 to 2022. Prior to his role at UNSW, Marcel was the Founding Chief Executive Officer of Genome.One, one of the first companies in the world to provide clinical whole genome sequencing services, and inaugural Head of the [http://www.garvan.org.au/research/kinghorn-centre-for-clinical-genomics/clinical-genomics Kinghorn Centre for Clinical Genomics] (KCCG) at the [https://garvan.org.au/ Garvan Institute of Medical Research]. As CEO of Genome.One, he brought together his expertise in informatics, biology and business to manage and direct a world-class clinical genomics service. As Head of KCCG, Marcel led a translational research laboratory that aimed to realise the utility of genomic medicine in routine clinical practice and explore the clinical value of non-protein-coding regions of the genome. Prior to moving to Sydney, Marcel headed the Cancer Transcriptomics laboratory at the [http://www.di.uq.edu.au/ Diamantina Institute] at the [http://www.uq.edu.au/ University of Queensland]. Marcel undertook his postdoctoral studies at the [http://imb.uq.edu.au/ Institute for Molecular Bioscience] where he studied the role of long noncoding RNAs in mammalian development and disease. During his postdoc, Marcel led a number of key studies demonstrating the dynamic and specific expression of long noncoding RNAs that prompted extensive functional studies of these transcripts that were commonly assumed to be “junk”.

Marcel Dinger - Recent changes [en]

Marcel Dinger - Profile